Ocunovis™ ProCare BioHAnce™ Gel Eye Drops with Amino Acids

Lubrication designed to last longer

Get the pet owner preferred, glob-free product for dry eye in cats and dogs1

  • The only gel eye drops with patented BioHAnce™ crosslinked hyaluronic acid (HA) designed and tested for pets: Ocunovis™ Procare uniquely contains a patented hyaluronic acid polymer gel technology and is one of the only lubricating eye drops supported by masked clinical studies.1
  • Clinically proven: One of the only lubricating eye drops with masked clinical studies for pets proven to dramatically improve the symptoms associated with dry eye.1 Ocunovis™ ProCare acts as artificial tears but does not treat or cure the underlying causes of dry eye.
  • Engineered for busy pet parents: Longer lasting lubrication means fewer applications and increased pet comfort.
  • Pet owners are happier with Ocunovis ProCare*: 8 out of 10 dog owners rated Ocunovis™ as highly effective, compared with only 2 out of 10 for the alternative tear supplement.1
  • Easier application: Unlike some products that contain multiple viscous ingredients which can create a “glob” of product when applied, Ocunovis™ ProCare creates a sheer, aqueous barrier that doesn’t cause blurred vision.
  • Industry accepted: Millions of doses of BioHAnce™ technology have been sold to veterinarians.2
  • Developed, manufactured, and studied in the United States.
  • Veterinary exclusive: Only sold to veterinary clinics through authorized distributors.
  • New ergonomic bottle is easier to hold and dispense.


Sentrx™ Animal Care is a veterinary medical device company that develops and manufactures veterinary wound care and ophthalmic products for companion animals. Sentrx™ transforms complex biotechnologies, including patented BioHance™  formulations, into easy-to-use care solutions that promote the long-term well-being of animals.

Sentrx™ was founded on technology from the University of Utah and collaborates with a variety of veterinary academic institutions and practicing veterinarians. The company’s unique combination of medicinal chemistry, bioengineering, and product manufacturing capabilities allow it to deliver cutting-edge animal care solutions.


1 Williams DL, Mann BK (2014) Efficacy of a Crosslinked Hyaluronic Acid-Based Hydrogel as a Tear Film Supplement: A Masked Controlled Study. PLoS ONE 9(6): e99766.
2 Represents the portfolio of eye and wound care products under various brand globally that incorporated the corresponding version of patented BioHAnce Technology.
*Referenced as cross-linked hyaluronic acid based hydrogel (xCMHA S) in study. Brand product name is Ocunovis™.